Exchange: NASDAQ·Updated 07:57 PM EDT
MRKR logo

MRKR Marker Therapeutics Inc

$1.18
$0.06
(4.84%)
Today
Closed $1.18
$0.02
(1.70%)
After Hours
Mkt Cap$19.67M
Vol35,610.00

About MRKR

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
54

Neutral Sentiment

How do you feel about MRKR?

Advertisement|Remove ads.